1 – 10 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Hepatitis C virus attributable liver cancer in the country of Georgia, 2015–2019 : a case–control study
(
- Contribution to journal › Article
- 2023
-
Mark
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers
(
- Contribution to journal › Article
-
Mark
Some epidemiological aspects of liver cirrhosis and hepatocellular carcinoma in Sweden
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma : A nationwide cohort study of 3473 patients
(
- Contribution to journal › Article
-
Mark
Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior
(
- Contribution to journal › Article
-
Mark
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
(
- Contribution to journal › Article
-
Mark
Irreversible electroporation of hepatocellular carcinoma and colorectal cancer liver metastases : A nationwide multicenter study with short- and long-term follow-up
(
- Contribution to journal › Article
- 2022
-
Mark
Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma
(
- Contribution to journal › Article
-
Mark
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country
(
- Contribution to journal › Article
- 2021
-
Mark
Metabolic perturbations prior to hepatocellular carcinoma diagnosis : Findings from a prospective observational cohort study
(
- Contribution to journal › Article